Radioactive iodine therapy, molecular imaging and serum biomarkers for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology, Pathology, Biology, Endocrine Surgery and Head and Neck Surgery-Reference-Cited by-同舟云学术

Radioactive iodine therapy, molecular imaging and serum biomarkers for differentiated thyroid cancer: 2017 guidelines of the French Societies of Nuclear Medicine, Endocrinology, Pathology, Biology, Endocrine Surgery and Head and Neck Surgery

Published:2017-07 Issue:3 Volume:78 Page:162-175
ISSN:0003-4266
Container-title:Annales d'Endocrinologie
language:en
Short-container-title:Annales d'Endocrinologie

Author:

Zerdoud Slimane,Giraudet Anne-Laure,Leboulleux Sophie,Leenhardt Laurence,Bardet Stéphane,Clerc Jérôme,Toubert Marie-Elisabeth,Al Ghuzlan Abir,Lamy Pierre-Jean,Bournaud Claire,Keller Isabelle,Sebag Frédéric,Garrel Renaud,Mirallié Eric,Groussin Lionel,Hindié Elif,Taïeb David

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference78 articles.

1. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods;Qaseem;Ann Intern Med,2010

2. Thyroid cancer mortality and incidence: a global overview;La Vecchia;Int J Cancer,2015

3. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis;Vaccarella;N Engl J Med,2016

4. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer;Mazzaferri;J Clin Endocrinol Metab,2001

5. The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer;Van Nostrand;Thyroid,2009

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status;Journal of Endocrinological Investigation;2024-04-05

2. Diffuse Bone Uptake of 131I and Effect on Blood Counts in a Patient With Papillary Thyroid Carcinoma and Chronic Lymphocytic Leukemia;Clinical Nuclear Medicine;2024-02-09

3. Clinical Benefit of Radioiodine Administration in a Rare Case of Iodine Avid Thyroid Carcinoma with No Secretion of Thyroglobulin;World Journal of Nuclear Medicine;2023-12

4. Current practice in intermediate risk differentiated thyroid cancer – a review;Reviews in Endocrine and Metabolic Disorders;2023-11-23

5. Radioactive Iodine in Differentiated Thyroid Carcinoma: A Systematic AGREE II Clinical Practice Guideline Appraisal;Otolaryngology–Head and Neck Surgery;2023-09-11